- Orca Bio is a late-stage biotechnology company specializing in high-precision cell therapies for hematologic malignancies and autoimmune diseases, aiming to redefine the transplant process with significantly better outcomes and reduced risks.
- In January 2026, Orca Bio announced $250 million in aggregate financing to prepare for the potential commercialization of its lead product, Orca-T, while the FDA extended the review timeline for its Biologics License Application to July 6, 2026.
- Orca Bio has presented promising clinical data at major conferences, including the 2026 Tandem Meetings of ASTCT® and CIBMTR®, showcasing the efficacy of Orca-T and Orca-Q® in improving patient outcomes with reduced graft-versus-host disease (GVHD).
- The ideal buyers for Orca Bio's therapies are healthcare providers and institutions treating blood cancers, as they address significant pain points in patient outcomes and safety in transplant procedures, making Orca Bio a key player to watch in the evolving cell therapy market.
Engineering is Orca Bio’s largest team with 43 employees, accounting for about one-third of the company’s total staff and highlighting the technical focus required for advanced cell therapy manufacturing. Healthcare and Operations follow closely with 20 employees each, reflecting the company’s clinical orientation and the operational rigor needed in regulated environments. Business Management (15 employees), Quality (10), and Finance & Administration (9) provide essential support functions, while Marketing & Product (8) drives market readiness. Smaller groups in Risk, Safety & Compliance and Sales & Support ensure governance and customer engagement, and an additional 7 employees are distributed across other specialized roles.
Orca Bio’s workforce is primarily based in California. Sacramento hosts the largest contingent with 46 employees, leveraging proximity to the company’s manufacturing and R&D activities. The San Francisco office employs 24 people, offering access to the Bay Area’s biotech ecosystem. Beyond these hubs, staff are spread across Seattle, Los Angeles, Palo Alto, and several smaller sites such as Bloomington, Hayward, West Sacramento, and Vacaville. An additional 47 employees are categorized under other or remote locations, indicating a flexible approach to talent placement.
